Environmental, Social and Governance Overview

“Responsibility is at the heart of what we do.”

Jay Luly bio picture

Our vision at Enanta is clear: to transform the lives of patients with curative therapies. Our mission underscores how we accomplish this vision, through scientific excellence and imagination, and by leveraging our expertise in small molecule drugs to discover and develop groundbreaking medicines.

Our culture, which emphasizes excellent science and patient commitment, supports our vision and mission. Our C.R.E.A.T.E values inform and embody this culture and commitment. These values include mutual respect through words and actions as well as working collaboratively in an inclusive environment to achieve common goals. We strive daily to abide by these values.

We have produced this new Environmental, Social and Governance (ESG) website to connect, in one location, relevant information on our commitment to ESG disclosure. Our disclosures reflect what is important within the context of Enanta: a small U.S. organization with less than 200 employees, two leased buildings, outsourced manufacturing and out-licensed commercialization of our first two product candidates.

We invite you, our stakeholders, to review our ESG website and to reach out with any feedback.

Jay R. Luly, Ph.D.
President, Chief Executive Officer and Director

2022 Accomplishments

Established formal ESG Working Group and appointed Co-Chairs

Convened meetings of ESG Working Group to establish 2022-2023 goals and identify disclosures

Formalized and published Enanta’s Vision, Mission and Values on the www.enanta.com website

Launched a new ESG website

Performed an initial quantitative assessment of our environmental footprint